SUMMARY Sixteen patients presented with B cell leukaemia (white cell count 26-269 x 109/1) which could not be classified as chronic lymphocytic (CLL), prolymphocytic leukaemia, or follicular lymphoma in leukaemic phase. Eleven patients (10 men, one woman) corresponded histologically to intermediate (INT) or mantle zone lymphoma, and five, with less well defined features, were designated small lymphocytic lymphoma with cleaved cells. The blood films showed a pleomorphic picture with lymphoid cells of predominantly medium size with nuclear irregularities and clefts. The membrane phenotype of the circulating cells showed strong immunoglobulin staining and reactivity with CD5 and FMC7 in all cases tested; CD1O was positive in six out of nine cases. The membrane phenotype of two of the five cases of small lymphocytic lymphoma was close to those of B-CLL and three resembled INT lymphoma. Bone marrow trephine biopsy specimens showed a diffuse pattern of infiltration in INT lymphoma. The median survival of these patients was less than two years, suggesting that a leukaemic presentation is associated with poor prognosis. By combining data from histology, membrane markers, and peripheral blood morphology, the leukaemic phase oftypical INT lymphoma can be defined in most cases.
Intermediate (INT) lymphoma or mantle zone lymphoma is a form of non-Hodgkin's lymphoma (NHL) characterised by a predominantly diffuse or vaguely nodular proliferation of atypical small lymphoid cells effacing the nodal architecture.' This lymphoma has not been included specifically in any of the major classification schemes. In the Working Formulation,2 however, most cases would be assigned to the category of small cleaved type with an intermediate prognostic grade, and in the Kiel classification3 these would be included in the centrocytic type of NHL. INT lymphoma is a B cell tumour with a mature phenotype and a characteristic expression of the p67 antigen (CD5).45 So far, no detailed study of the leukaemic manifestations of this lymphoma has been published. This may be due to the rarity of this phenomenon or perhaps because some of these cases are misdiagnosed as chronic lymphocytic leukaemia (CLL). This study reports the clinical, morphological, and immunological findings of 11 cases of INT (mantle zone) lymphoma in leukaemic phase which presented with a high white cell count. We were particularly interested to identify any clinical or pathological features which might be of help in the Accepted for publication 12 April 1989 differential diagnosis between this disorder and CLL, or its variants, and other NHL in leukaemic phase such as follicular lymphoma.6 A comparison was made with some cases which exhibited cytological atypia in excess of that seen in CLL and in which the possible diagnosis of INT lymphoma was suspected.
Material and methods
Diagnostic material from 16 patients with B lymphoproliferative disorders in frank leukaemic phase was included in this study. The patients were selected over a period ofthree years, between 1985 and 1987, among cases of chronic B cell leukaemias submitted to our laboratory for marker studies. These cases were referred with a diagnosis of CLL or prolymphocytic leukaemia (B-PLL) or of lymphoid leukaemia of an unspecified nature.
The morphological detail of the circulating cells was studied by light microscopy on peripheral blood films stained with May-Gruiwald Giemsa. Histological sections stained with haematoxylin and eosin from the following affected tissues were also reviewed: lymph nodes (n = 9); spleen (n = 3); bone marrow trephine biopsy specimens (n = 16). Table 2 compares the features of the circulating lymphocytes of the cases analysed here with those of typical CLL cells, described elsewhere.6 Overall, the cases in this series showed consistent cell size heterogeneity and cellular pleomorphism, while INT lymphoma is often seen in middle aged to elderly men and presents with lymph node enlargement, splenomegaly, and bone marrow disease.9 Only a few cases presenting with a florid leukaemic phase have been reported.49 The highest lymphocyte count previously recorded is 32-9 x 109/l. In our cases the white cell count ranged from 26 to 269 x 109/l and the circulating lymphocytes were predominantly a mixture ofsmall, medium, and large size cells with a visible amount of cytoplasm and a round nucleus with angular and often cleaved features; nucleoli were conspicuously seen in a relatively high proportion of cells. Melo et al described a group of 84 patients among a series of 300 that were designated CLL with an increase in prolymphocytes (CLL/PL), selected on morphological grounds by the presence in peripheral blood films of small lymphocytes and a proportion of prolymphocytes (10% to 50% of cells).'°In this group of CLL/PL the membrane phenotyping markers showed a closer affinity to CLL than to PLL, such as a high percentage ofM-rosettes, constant positivity with CD5, and low reactivity with FMC7. In our group of INT lymphomas the membrane markers were different from those oftypical CLL and CLL/PL because they had no affinity to form M-rosettes (only two out of nine cases), SmIg was strongly expressed, FMC7 growth centres containing prominent prolymphocytes and the absence of cells with finely distributed or "blastic" chromatin. Despite the differences recorded in histology, peripheral blood picture, and phenotype, conclusive evidence that these cases correspond to INT NHL or to CLL was absent. Perhaps the application of molecular genetic or cytogenetic markers may allow such cases to be appropriately classified in future. It is concluded that by combining histology, membrane markers, and peripheral blood morphology, the leukaemic phase of typical INT lymphoma can be defined in most cases. It is difficult, with a small series, to draw definitive conclusions about the natural history ofthe disease or the prognostic importance ofa leukaemic phase in INT lymphoma. It is worth noting, however, that half of the patients (four of eight) for whom follow up information was available died in less than two years, a feature also observed in cases of follicular lymphoma presenting with a high white cell count.6 Although the numbers are small, those cases classified as small lymphocytic lymphoma with cleaved cells seem to have a somewhat better prognosis, closer to that of classic B-CLL.
